Cargando…

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012

OBJECTIVE: To evaluate clinical trial registration, reporting and publication rates for new drugs by: (1) legal requirements and (2) the ethical standard that all human subjects research should be publicly accessible to contribute to generalisable knowledge. DESIGN: Cross-sectional analysis of all c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Jennifer E, Korn, David, Ross, Joseph S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Ethics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654354/ https://www.ncbi.nlm.nih.gov/pubmed/26563214 http://dx.doi.org/10.1136/bmjopen-2015-009758

Ejemplares similares

Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
por: Zou, Constance X., et al.
Publicado: (2018)

Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
por: Swanson, Matthew J., et al.
Publicado: (2021)

Prospective registration trends, reasons for retrospective registration and mechanisms to increase prospective registration compliance: descriptive analysis and survey
por: Hunter, Kylie Elizabeth, et al.
Publicado: (2018)

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
por: Miller, Jennifer E, et al.
Publicado: (2017)

A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa
por: Limaye, Dnyanesh, et al.
Publicado: (2015)

Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review
por: Rogers, Wendy, et al.
Publicado: (2019)

Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis
por: Axson, Sydney A, et al.
Publicado: (2021)

Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
por: Talebi, Ramtin, et al.
Publicado: (2020)

Registration audit of clinical trials given a favourable opinion by UK research ethics committees
por: Denneny, Carla, et al.
Publicado: (2019)

Association of the FDA Amendment Act with trial registration, publication, and outcome reporting
por: Phillips, Adam T., et al.
Publicado: (2017)

Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
por: Jones, Christopher W, et al.
Publicado: (2016)

UK universities compliance with the Concordat to Support Research Integrity: findings from cross-sectional time-series
por: Wager, Elizabeth
Publicado: (2019)

Biomedical authors’ awareness of publication ethics: an international survey
por: Schroter, Sara, et al.
Publicado: (2018)

Approaches to consent in public health research in secondary schools
por: Bonell, Chris, et al.
Publicado: (2023)

Developing a typology of the roles public contributors undertake to establish legitimacy: a longitudinal case study of patient and public involvement in a health network
por: Barker, Jacqueline, et al.
Publicado: (2020)

Monitoring of approved studies: A difficult tightrope walk by Ethics Committees
por: Davis, Sanish
Publicado: (2018)

Current Experience of Central versus Local Ethics Approval in Multicentre Studies
por: Watling, M I L, et al.
Publicado: (1993)

Attitudes on cost-effectiveness and equity: a cross-sectional study examining the viewpoints of medical professionals
por: Li, David G, et al.
Publicado: (2017)

Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study
por: Morrow, Richard L, et al.
Publicado: (2023)

Which factors should be included in triage? An online survey of the attitudes of the UK general public to pandemic triage dilemmas
por: Wilkinson, Dominic, et al.
Publicado: (2020)

Use of surrogate outcomes in US FDA drug approvals, 2003–2012: a survey
por: Yu, Tsung, et al.
Publicado: (2015)

Cross-sectional survey of Good Samaritan behaviour by physicians in North Carolina
por: Garneau, William M, et al.
Publicado: (2016)

Public involvement and engagement in big data research: protocol for a scoping review and a systematic review of delivery and effectiveness of strategies for involvement and engagement
por: Teodorowski, Piotr, et al.
Publicado: (2021)

Determining the level of data sharing, and number of publications, from research databases that have been given a favourable opinion by UK research ethics committees
por: Trace, Samantha, et al.
Publicado: (2020)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

FDAAA legislation is working, but methodological flaws undermine the reliability of clinical trials: a cross-sectional study
por: Marin dos Santos, Douglas H., et al.
Publicado: (2015)

Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Doctors’ willingness to give honest answers about end-of-life practices: a cross-sectional study
por: Merry, Alan F, et al.
Publicado: (2013)

Why articles are retracted: a retrospective cross-sectional study of retraction notices at BioMed Central
por: Moylan, Elizabeth C, et al.
Publicado: (2016)

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
por: Ozaki, Akihiko, et al.
Publicado: (2019)

Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
por: Strzebonska, Karolina, et al.
Publicado: (2020)

A cross-sectional examination of conflict-of-interest disclosures of physician-authors publishing in high-impact US medical journals
por: Baraldi, James H, et al.
Publicado: (2022)

Alchemical analysis of FDA approved drugs
por: Orsi, Markus, et al.
Publicado: (2023)

Parental attitudes and willingness to donate children’s biospecimens for congenital heart disease research: a cross-sectional study in Shanghai, China
por: Gao, Hongxiang, et al.
Publicado: (2018)

Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
por: Shearman, Kirstie, et al.
Publicado: (2022)

Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials
por: Hoogerwerf, Marie-Astrid, et al.
Publicado: (2020)

Characteristics and trends of clinical studies primarily sponsored by China in WHO primary registries between 2009 and 2018: a cross-sectional survey
por: Xu, Yang, et al.
Publicado: (2020)

Extent of awareness and attitudes on plagiarism among post-graduate resident doctors and junior medical faculty in India: a cross-sectional, multicentric study
por: Raj, Jeffrey Pradeep, et al.
Publicado: (2021)

Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study
por: Chappuy, Hélène, et al.
Publicado: (2013)

Conflict of interest disclosure slides at the European Society of Cardiology Congress 2016 in Rome: are they displayed long enough to assess their content? A cross-sectional study
por: van Lieshout, Christianne T, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eu2f7flruabaeeo5g7ag8ki0lc